F-star Therapeutics, Inc.
DelistedCIK 1566373fmd_1WWWWNE01RX7TY1Q20AFTB6RFEManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Sep 30, 2022, 31 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 28 | 11 | 21 |
| Research and development | 8 | 14 | 13 | 20 | 31 | 14 | 29 |
| Operating income | (12) | (19) | (21) | (28) | (22) | (22) | (31) |
| Interest expense | – | – | – | – | 1 | 1 | 1 |
| Other non-operating income (expense) | – | – | – | – | 0 | (3) | (1) |
| Income before taxes | – | – | – | – | (24) | (26) | (32) |
| Income tax expense | – | 0 | 0 | 0 | (1) | (0) | (0) |
| Net income from continuing operations | – | – | – | – | (23) | (26) | (31) |
| Net income | (12) | (17) | (28) | (23) | (23) | (26) | (31) |
| Net income to common shareholders | – | – | (28) | (27) | (23) | (26) | – |